Therapeutic HIV Vaccine and Interleukin-2 to Increase the Immune System's Response to HIV
Clinical trial NCT00056797 · COMPLETED
Trial details
- NCT number
- NCT00056797
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2002-03-01
- Primary completion
- 2006-03-01
- Enrollment
- 92
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.